Clinical Trial Update: SERIES III RUN-IN Clinical Trial: A Comparison of the Supralimus® Stent With the Xience V™ Stent [Phase 4]

View source ↗

Summary

This Phase 4 trial comparing the Supralimus stent with the Xience V stent in coronary artery disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Supralimus Stent
• Xience V Stent (Everolimus-eluting stent)

Snippet

Sponsor: Sahajanand Medical Technologies Limited | Conditions: Coronary Artery Disease | Phase 4 | Status: TERMINATED